Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six middle eastern countries

Journal of Clinical Hypertension

Volumn 12, Issue 11, 2010, Pages 890-899

  Al Suwaidi, Jassim ^a   Zubaid, Mohammad ^b   El Menyar, Ayman A ^a   Singh, Rajvir ^a,c   Rashed, Wafa ^d   Ridha, Mustafa ^e   Shehab, Abdulla ^f   Al Lawati, Jawad ^g   Amin, Haitham ^h   Al Mottareb, Ahmed ⁱ  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b KUWAIT UNIVERSITY   (Kuwait)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^d MUBARAK AL KABEER HOSPITAL   (Kuwait)

^e ADAN HOSPITAL   (Kuwait)

^f UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^g MINISTRY OF HEALTH   (Oman)

^h BAHRAIN DEFENCE FORCE HOSPITAL   (Bahrain)

ⁱ University of Sana   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BODY MASS; CARDIAC PATIENT; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART RATE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE EAST; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; REVASCULARIZATION; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 78249240907     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00371.x     Document Type: Article

References (26)

1. Zimmet P, Magliano D, Matsuzawa Y. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12:295-300.
2. Zeller M, Steg PG, Ravisy J, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005;165:1192-1198.
3. Boulon C, Lafitte M, Richeboeuf V, et al. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance. Am J Cardiol. 2006;89:1429-1434.
4. Clavijo LC, Pinto TL, Kuchulakanti RT, et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med. 2006;7:7-11.
5. Celik T, Turhan H, Kursaklioglu H, et al. Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Coron Artery Dis. 2006;17:339-343.
6. Chung EH, Curran PJ, Sivasankaran S, et al. Prevalence of metabolic syndrome in patients ≥45 years of age with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol. 2007;100:1052-1055.
7. Milionis HJ, Kalantzi KJ, Papathanasiou AJ, et al. Metabolic syndrome and risk of acute coronary syndromes in patients younger than 45 years of age. Coronary Artery Dis. 2007;18:247-252.
8. Prasad S, Fahratsh F, Malaipan Y, et al. Obesity and the metabolic syndrome in patients with acute myocardial infarction. Int J Cardiol. 2009 Apr 6. [Epub ahead of print].
9. Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on long-term survival of patients with acute myocardial infarction. Circ J. 2008;72:415-419.
10. Yasar AS, Bilen E, Bilge M, et al. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction. Coron Artery Dis. 2009;20:387-391.
11. Koutsovasilis A, Protopsaltis J, Triposkiadis F, et al. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome. Intern Med. 2009;48:179-187.
12. Dohi T, Miyauchi K, Kasai T, et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J. 2009;73:1454-1458.
13. Levantesi G, Macchia A, Marfisi RM, et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2005;46:277-283.
14. Girman CJ, Rhodes T, Mercuri M, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol. 2004;93:136-141.
15. Schwartz GG, Szarek M, Olsson AG, et al. Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome. Diabetes Care. 2005;28:1508-1513.
16. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
17. El-Menyar A, Zuabid M, Rashed W, et al. Comparison of men and women with acute coronary syndrome in six Middle Eastern countries. Am J Cardiol. 2009;104(8):1018-1022.
18. Alsheikh-Ali AA, Al-Mallah MZ, Al Mahmeed W, et al. Heart failure in patients hospitalized with acute coronary syndrome: observations from the Gulf Registry of acute coronary syndrome. Eur J Heart Fail. 2009;11(12):1135-1142.
19. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with cute coronary syndrome. Circulation. 2002;106:974-980.
20. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis after myocardial infarction in patients without diabetes mellitus. Am J Cardiol. 1989;64:885-888.
21. O'Sullivan JJ, Conroy RM, Robinson K, et al. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care. 1991;14:758-760.
22. Leor J, Goldbourt U, Reicher-Reiss H, et al. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission. Am J Med. 1993;226:297-301.
23. Serebrany VL, Malinin A, Ong S, et al. Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease. J Thromb Thrombolysis. 2008;25:207-213.
24. Arenillas JF, Ispierto L, Millan M, et al. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke. Neurology. 2008;71:190-195.
25. Anand SS, Yi Q, Gerstein H, et al. Relationship of metbolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation. 2003;108:420-425.
26. Mente A, Yusuf S, Islam S, et al. Metabolic syndrome and risk of acute myocardial infarction: a case-control study of 26, 903 subjects from 52 countries. J Am Coll Cardiol. 2010;55(21):2390-2398.